ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis

NCT03923478 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Ulcerative Colitis Chronic Mild
Ulcerative Colitis Chronic Moderate

Interventions

DRUG: ABI-M201
DRUG: Placebo

Sponsor

Assembly Biosciences